Clinical reference Biomarker Directory
Back to directory

Neurofilament Light Polypeptide

Emerging

NfL is a rapidly emerging blood biomarker of neuroaxonal damage, now guided by a 2024 consensus statement for MS management.

Also known as NfL neurofilament light chain
In plain language

NfL is released when nerve cells are damaged, and a simple blood test can now measure it (a big improvement over needing a spinal tap). It helps track disease activity in multiple sclerosis and is being studied across several other brain and nerve diseases too.

Biomarker & context

Neurofilament light chain (NfL) is a structural neuronal protein released into blood and cerebrospinal fluid when neuroaxonal damage occurs, serving as a general marker of neurological injury across multiple conditions.

What it indicates

Elevated or rising NfL reflects ongoing neuroaxonal damage; it's studied and increasingly used across multiple sclerosis, Alzheimer's disease, ALS, and other neurodegenerative conditions as a marker of disease activity and progression.

Diagnosis & clinical testing

A formal 2024 international consensus statement now guides NfL use specifically in multiple sclerosis management, where elevated or rising serum NfL helps predict disease activity and monitor treatment response, complementing (not replacing) MRI.

Guiding treatment

Blood-based NfL testing is now practical where only invasive spinal fluid testing existed before, thanks to newer ultra-sensitive assay technology; ongoing challenges include standardizing assays and establishing clear reference values, since factors like age and kidney function can also affect results.

Clinical significance

Blood-based testing (rather than only spinal fluid) is a genuinely practical recent advance, expanding accessibility for monitoring.

References
  1. PMC. (2024). Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management.
  2. PMC. (2025). Advancing Clinical Use of Neurofilament Light Chain: Translational Insights From Research to Routine Practice.